Evidence map›Paper›PMID 33720817›Full record

ArticleMicrobial genomics2021

Transmission, adaptation and geographical spread of the

Matthew P Moore, Iain L Lamont, David Williams, Steve Paterson, Irena Kukavica-Ibrulj, Nicholas P Tucker, Dervla T D Kenna, Jane F Turton, Julie Jeukens, Luca Freschi and 10 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. An extragenic fix for a broken enzyme.Microbiology (Reading, England) · 2026
    Article
  2. Article
  3. Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail againstPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  4. Article
  5. Evolution and host-specific adaptation ofScience (New York, N.Y.) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Competitive fitness ofFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 5 countries.

Matthew P MooreInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Iain L LamontDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
David WilliamsInstitute of Integrative Biology, University of Liverpool, Liverpool, UK.
Steve PatersonInstitute of Integrative Biology, University of Liverpool, Liverpool, UK.
Irena Kukavica-IbruljInstitute for Integrative and Systems Biology, Université Laval, Quebec City, QC, Canada.
Nicholas P TuckerStrathclyde Institute of Pharmacy & Biomedical Sciences. University of Strathclyde, Glasgow, UK.
Dervla T D KennaNational Infection Service, Public Health England, London, UK.
Jane F TurtonNational Infection Service, Public Health England, London, UK.
Julie JeukensInstitute for Integrative and Systems Biology, Université Laval, Quebec City, QC, Canada.
Luca FreschiPresent address: Harvard Medical School, Boston, MA, USA.
Bryan A WeePresent address: Usher Institute, University of Edinburgh, Edinburgh, UK.
Nicholas J LomanInstitute for Microbiology & Infection, University of Birmingham, Birmingham, UK.
Stephen HoldenPresent address: MSD Research Laboratories, Two Pancras Square, London, UK.
Susan ManzoorUniversity Hospitals Birmingham, Heartlands Hospital, Bordesley Green East, Birmingham, UK.
Peter HawkeyPresent address: University of Birmingham Microbiome Treatment Centre, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Kevin W SouthernAlder Hey Children's Hospital, Liverpool, UK.
Martin J WalshawLiverpool Heart and Chest Hospital, Liverpool, UK.
Roger C LevesqueInstitute for Integrative and Systems Biology, Université Laval, Quebec City, QC, Canada.
Joanne L FothergillInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Craig WinstanleyInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
University of Liverpool · GBUniversité Laval · CAPublic Health England · GBUniversity of Birmingham · GBHarvard University · USHeartlands Hospital · GBNottingham University Hospitals NHS Trust · GBThe University of Queensland · AUUniversity of Otago · NZUniversity of Strathclyde · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Liverpool epidemic strain (LES) is an important transmissible clonal lineage of

Indexed as

Adaptation, PhysiologicalCanadaCystic FibrosisEpidemicsGenome, BacterialHumansLungOpportunistic InfectionsPhylogenyPseudomonas aeruginosaPseudomonas InfectionsUnited Kingdomcystic fibrosisgenomicsprophagePseudomonas aeruginosa

Identifiers

PMID33720817
PMCPMC8190615
OpenAlexW3127018168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.